CPRD Feasibility Tool

The MHRA is seeking a white-labelled feasibility and population analytics platform to be deployed within CPRD-managed Microsoft Azure infrastructure in the United Kingdom. The solution must natively support the OMOP Common Data Model without requiring material restructuring of CPRD datasets. The platform is intended to enable CPRD staff and approved external clients to perform self-service descriptive epidemiological analyses and feasibility studies, including the ability to generate patient counts within 60 seconds, calculate incidence and prevalence, and construct cohorts based on demographics, observations, procedures, medications, and diagnoses. Key technical requirements include granular role-based access control, interactive exportable dashboards, and comprehensive audit logging. The contract, identified as C472732, has an estimated total value of 3,000,000 GBP excluding VAT, with the possibility of two one-year extensions. Award decisions are based on a two-stage process: a written submission evaluating quality (90%) and social value (10%), followed by a presentation and demonstration for the top three compliant tenderers. The agreement is governed by a Short Form Contract where the buyer retains ownership of all new intellectual property. Security requirements mandate that the supplier only handle data classified as OFFICIAL and ensure all data resides within the UK. Payment for undisputed invoices is processed within 30 days of receipt.